Assembly Biosciences, Inc. Noncash or Part Noncash Acquisition, Payables Assumed
Assembly Biosciences, Inc. (ASMB) reported Noncash or Part Noncash Acquisition, Payables Assumed of -$99.21 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1 · last filed 2016-03-11
- Assembly Biosciences, Inc. noncash or part noncash acquisition, payables assumed for the quarter ending 2015-12-31 was -$99.21K, a 200.00% decline year-over-year.
- Assembly Biosciences, Inc. noncash or part noncash acquisition, payables assumed for the quarter ending 2014-12-31 was $99.21K.
- Assembly Biosciences, Inc. noncash or part noncash acquisition, payables assumed for the quarter ending 2013-12-31 was $0.00.
- Assembly Biosciences, Inc. noncash or part noncash acquisition, payables assumed for fiscal 2015 was -$99.21K, a 111.35% decline from fiscal 2014.
- Assembly Biosciences, Inc. noncash or part noncash acquisition, payables assumed for fiscal 2014 was $874.11K.
- Assembly Biosciences, Inc. noncash or part noncash acquisition, payables assumed for fiscal 2013 was $0.00.
| Period end | Noncash or Part Noncash Acquisition, Payables Assumed 3 month | Noncash or Part Noncash Acquisition, Payables Assumed 9 month | Noncash or Part Noncash Acquisition, Payables Assumed 9 month as first filed | Noncash or Part Noncash Acquisition, Payables Assumed 12 month |
|---|---|---|---|---|
| 2015-12-31 | -$99.21K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | -$99.21K 10-K · filed 2016-03-11 | ||
| 2015-09-30 | $0.00 10-Q · filed 2015-11-09 | |||
| 2014-12-31 | $99.21K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $874.11K 10-K · filed 2016-03-11 | ||
| 2014-09-30 | $774.90K 10-Q · filed 2015-11-09 | $874.11K 10-Q · filed 2014-11-17 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $0.00 10-K · filed 2015-03-16 | ||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |